Anthropic cuts Fable 5.1 prices by 25% and launches two-tier safeguard system with Mythos 5.1

The discount is a change to one line item rather than a cut across the bill. Anthropic attributes it to lower pricing on cache reads, the inputs a model has already processed and stored ^[11]. That is also why the same release can put up to roughly 45% next to highly agentic work ^[12]: an agent loop re-reads a large, stable context on almost every turn, so most of its input tokens are cache reads, while a workload that sends fresh text on each call has few of them. Anyone planning next quarter's spend off the headline percentage is really modelling their own workload mix.

The spread is worth sizing before it reaches a budget line. A team spending a million dollars a year on Fable 5 tokens lands near $750,000 at the typical saving and near $550,000 if its work sits at the agentic end, a gap of about $200,000 that turns entirely on how much context is re-read rather than resent ^[14].

Price is the easier half of this release. Anthropic presents Fable 5.1 as a response to customer feedback on price, data retention and safeguards ^[9], and the biology capability it treats as most sensitive now reaches users through an access program developed with the US government, with enrollment for scientists still to open ^[8]. That changes the shape of an internal request. A research lead who wants that capability is applying for a credential; the eligibility criteria are not in the announcement, and no budget holder can approve it alone.

Vendor estimates of a vendor's own savings, and a vendor's own account of its safeguards, remain marketing claims until something outside the vendor confirms them, and the quality evidence on offer includes a single customer anecdote, the rare crash at the investment firm Millennium that its engineers and other models had not explained in years ^[15]. One half of that holds up inside a billing cycle, since the cache-read share of token spend is already visible in invoices; the other does not, because a retention arrangement can be written into a contract and enforced, whereas what a safeguard blocks is asserted by the seller and cannot be inspected from the buyer's side.

The capability sitting behind the gate is the one carrying the most striking numbers. Anthropic reports that Mythos 5.1's protein designs reached a hit rate of nearly 50% across twelve targets, against the 10-15% it describes as typical in protein design today ^[4], which is roughly three to five times the field norm ^[10]. If that survives replication by people who do not work at Anthropic, then the commercially interesting tier is the one most customers cannot buy, and the price cut is on the tier they can. For now that reads as a budget revision; going forward, what matters is who inside the company is allowed to hold the credential.